Published in J Clin Oncol on December 01, 2001
Pilot Study Comparing Hypnotherapy and Gabapentin for Hot Flashes. | NCT00711529
Mechanical Device for the Relief of Hot Flashes | NCT01281332
Effects of stellate ganglion block on vasomotor symptoms: findings from a randomized controlled clinical trial in postmenopausal women. Menopause (2014) 2.70
Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol (2010) 2.57
Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.39
Beyond frequency: who is most bothered by vasomotor symptoms? Menopause (2008) 2.35
Yoga of Awareness program for menopausal symptoms in breast cancer survivors: results from a randomized trial. Support Care Cancer (2009) 1.95
Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. J Clin Oncol (2008) 1.93
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy. J Clin Oncol (2008) 1.91
Depression is associated with worse objectively and subjectively measured sleep, but not more frequent awakenings, in women with vasomotor symptoms. Menopause (2009) 1.67
Mindfulness training for coping with hot flashes: results of a randomized trial. Menopause (2011) 1.61
Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause (2009) 1.61
Mechanisms of cutaneous vasodilation during the postmenopausal hot flash. Menopause (2011) 1.48
Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol (2009) 1.46
Acupuncture for menopausal vasomotor symptoms: study protocol for a randomised controlled trial. Trials (2014) 1.41
Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause (2014) 1.31
Acupuncture for hot flashes in patients with prostate cancer. Urology (2010) 1.27
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort. Breast Cancer Res Treat (2009) 1.20
Cutaneous and hemodynamic responses during hot flashes in symptomatic postmenopausal women. Menopause (2008) 1.10
Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol (2009) 1.04
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol (2009) 1.00
Modeling hot flushes and quality of life in breast cancer survivors. Climacteric (2010) 1.00
Weight gain is associated with increased risk of hot flashes in breast cancer survivors on aromatase inhibitors. Breast Cancer Res Treat (2010) 0.99
Acupuncture improves health-related quality-of-life (HRQoL) and sleep in women with breast cancer and hot flushes. Support Care Cancer (2011) 0.96
Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5. J Clin Oncol (2010) 0.95
A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause (2012) 0.94
Switching to letrozole or exemestane improves hot flushes, mood and quality of life in tamoxifen intolerant women. Br J Cancer (2008) 0.90
Acupuncture and auricular acupressure in relieving menopausal hot flashes of bilaterally ovariectomized chinese women: a randomized controlled trial. Evid Based Complement Alternat Med (2010) 0.90
Escitalopram reduces hot flashes in nondepressed menopausal women: A pilot study. Ann Clin Psychiatry (2009) 0.89
The TU-025 keishibukuryogan clinical trial for hot flash management in postmenopausal women: results and lessons for future research. Menopause (2011) 0.89
Pilot evaluation of a stellate ganglion block for the treatment of hot flashes. Support Care Cancer (2010) 0.88
Electroacupuncture Versus Gabapentin for Hot Flashes Among Breast Cancer Survivors: A Randomized Placebo-Controlled Trial. J Clin Oncol (2015) 0.87
Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause (2013) 0.86
Sensitivity and specificity of recalled vasomotor symptoms in a multiethnic cohort. Am J Epidemiol (2008) 0.86
Acupuncture for treating hot flushes in men with prostate cancer: a systematic review. Support Care Cancer (2009) 0.85
A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat (2014) 0.85
Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA Cancer J Clin (2013) 0.84
Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause (2008) 0.84
Favorable modulation of benign breast tissue and serum risk biomarkers is associated with > 10 % weight loss in postmenopausal women. Breast Cancer Res Treat (2013) 0.84
Combination treatment of tamoxifen with risperidone in breast cancer. PLoS One (2014) 0.83
MODERATING EFFECT OF HYPNOTIZABILITY ON HYPNOSIS FOR HOT FLASHES IN BREAST CANCER SURVIVORS. Contemp Hypn Integr Ther (2011) 0.82
Melatonin effects on luteinizing hormone in postmenopausal women: a pilot clinical trial NCT00288262. BMC Womens Health (2006) 0.81
A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients. Support Care Cancer (2011) 0.79
Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study. BMJ Open (2013) 0.79
Miniature ambulatory skin conductance monitor and algorithm for investigating hot flash events. Physiol Meas (2014) 0.79
Levetiracetam for the treatment of hot flashes: a phase II study. Support Care Cancer (2007) 0.79
Review of hot flash diaries. Maturitas (2012) 0.78
The effect of TCM acupuncture on hot flushes among menopausal women (ACUFLASH) study: a study protocol of an ongoing multi-centre randomised controlled clinical trial. BMC Complement Altern Med (2007) 0.78
Hot flashes: the ongoing search for effective interventions. Menopause (2012) 0.78
Sternal skin conductance: a reasonable surrogate for hot flash measurement? Menopause (2013) 0.78
Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites. BMC Cancer (2013) 0.78
Efficacy of a non-hormonal treatment, BRN-01, on menopausal hot flashes: a multicenter, randomized, double-blind, placebo-controlled trial. Drugs R D (2012) 0.78
Reduction in menopause-related symptoms associated with use of a noninvasive neurotechnology for autocalibration of neural oscillations. Menopause (2015) 0.77
Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial. Menopause (2013) 0.77
A randomised trial of the cool pad pillow topper versus standard care for sleep disturbance and hot flushes in women on endocrine therapy for breast cancer. Support Care Cancer (2015) 0.76
Informing hot flash treatment decisions for breast cancer survivors: a systematic review of randomized trials comparing active interventions. Breast Cancer Res Treat (2016) 0.76
North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes. Menopause (2015) 0.76
Device-guided slow-paced respiration for menopausal hot flushes: a randomized controlled trial. Obstet Gynecol (2015) 0.76
Pooled Analysis of Six Pharmacologic and Nonpharmacologic Interventions for Vasomotor Symptoms. Obstet Gynecol (2015) 0.76
Acupuncture in Menopause (AIM) study: a pragmatic, randomized controlled trial. Menopause (2016) 0.76
The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis. J Cancer Res Clin Oncol (2013) 0.76
Measuring hot flash phenomenonology using ambulatory prospective digital diaries. Menopause (2016) 0.75
Venlafaxine for the treatment of hormonal therapy-induced hot flashes in a male patient. Prim Care Companion CNS Disord (2011) 0.75
Pilot study of integral yoga for menopausal hot flashes. Menopause (2014) 0.75
Effectiveness of Traditional Chinese Acupuncture versus Sham Acupuncture: a Systematic Review. Rev Lat Am Enfermagem (2016) 0.75
Bee pollen and honey for the alleviation of hot flushes and other menopausal symptoms in breast cancer patients. Mol Clin Oncol (2015) 0.75
Chlormadinone acetate is effective for hot flush during androgen deprivation therapy. Prostate Int (2013) 0.75
The effect of folic Acid on menopausal hot flashes: a randomized clinical trial. J Caring Sci (2013) 0.75
Study Protocol: effects of acupuncture on hot flushes in perimenopausal and postmenopausal women - a multicenter randomized clinical trial. Trials (2008) 0.75
Comparative effectiveness of electro-acupuncture versus gabapentin for sleep disturbances in breast cancer survivors with hot flashes: a randomized trial. Menopause (2016) 0.75
Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes. Support Care Cancer (2015) 0.75
Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial. Menopause (2016) 0.75
Trajectories of response to acupuncture for menopausal vasomotor symptoms: the Acupuncture in Menopause study. Menopause (2016) 0.75
Stellate ganglion blockade and verbal memory in midlife women: Evidence from a randomized trial. Maturitas (2016) 0.75
Chinese herbal medicine for menopausal symptoms. Cochrane Database Syst Rev (2016) 0.75
Exercise training reduces the acute physiological severity of post-menopausal hot flushes. J Physiol (2015) 0.75
Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet (2000) 4.43
Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA (1993) 3.91
It is now the age to define the appropriate follow-up of primary breast cancer patients. J Clin Oncol (1994) 3.00
Seed-specific over-expression of an Arabidopsis cDNA encoding a diacylglycerol acyltransferase enhances seed oil content and seed weight. Plant Physiol (2001) 2.31
Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol (1998) 2.24
Cancer screening behaviors and attitudes of women in southeastern Minnesota. JAMA (1995) 2.23
Alteration of seed fatty acid composition by an ethyl methanesulfonate-induced mutation in Arabidopsis thaliana affecting diacylglycerol acyltransferase activity. Plant Physiol (1995) 2.19
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol (2000) 2.11
Biosynthesis of Acyl Lipids Containing Very-Long Chain Fatty Acids in Microspore-Derived and Zygotic Embryos of Brassica napus L. cv Reston. Plant Physiol (1992) 2.06
Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol (1990) 1.74
Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol (1994) 1.67
Modification of seed oil content and acyl composition in the brassicaceae by expression of a yeast sn-2 acyltransferase gene. Plant Cell (1997) 1.66
Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med (1999) 1.63
Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther (2011) 1.62
Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: relationships and prognostic value. J Neurosurg (1997) 1.58
2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol (2000) 1.43
The Pine Ridge-Mayo National Aeronautics and Space Administration telemedicine project: program activities and participant reactions. Mayo Clin Proc (1996) 1.43
Soy for breast cancer survivors: a critical review of the literature. J Nutr (2001) 1.43
An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care (2001) 1.40
Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol (1999) 1.39
Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol (1991) 1.33
Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol (1994) 1.33
The plastidic phosphoglucomutase from Arabidopsis. A reversible enzyme reaction with an important role in metabolic control. Plant Physiol (2000) 1.31
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol (1998) 1.29
Triacylglycerol Bioassembly in Microspore-Derived Embryos of Brassica napus L. cv Reston. Plant Physiol (1991) 1.28
Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat (1999) 1.27
Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results. J Clin Oncol (1998) 1.26
Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol (1998) 1.23
Prognostic effect of activated EGFR expression in human colon carcinomas: comparison with EGFR status. Br J Cancer (2009) 1.18
Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys (1996) 1.16
Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage (1998) 1.15
Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA (1995) 1.15
Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol (1999) 1.15
A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol (2001) 1.12
Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol (1999) 1.08
Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol (1994) 1.07
Induction of adrenal suppression by megestrol acetate. Ann Intern Med (1996) 1.07
Megestrol acetate-induced adrenal suppression. J Clin Oncol (1996) 1.06
DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma. Cancer (1991) 1.05
Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer (1996) 1.03
Tamoxifen-induced hot flashes. Clin Breast Cancer (2000) 1.02
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol (2009) 1.00
Follow-up testing for curatively treated cancer survivors. What to do? JAMA (1995) 0.99
A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer (1990) 0.97
Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial. J Clin Oncol (2000) 0.97
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol (1997) 0.96
Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer (1998) 0.96
Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol (1995) 0.95
A randomized, crossover evaluation of methylphenidate in cancer patients receiving strong narcotics. Support Care Cancer (1995) 0.94
Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol (1996) 0.91
A qualitative approach to defining "hot flashes" in men. Urol Nurs (1994) 0.89
Use of orally administered opioids for cancer-related pain. Mayo Clin Proc (1994) 0.88
Regular use of a verbal pain scale improves the understanding of oncology inpatient pain intensity. J Clin Oncol (1994) 0.87
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer (1997) 0.87
Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol (1997) 0.87
Prostate-specific antigen decline after withdrawal of low-dose megestrol acetate. J Clin Oncol (1999) 0.87
Aggressive combined modality therapy for advanced local-regional breast carcinoma. J Clin Oncol (1984) 0.86
A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer (1997) 0.86
A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma. J Neurooncol (2000) 0.85
Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer. J Clin Oncol (1986) 0.85
Sex differences in fluorouracil-induced stomatitis. J Clin Oncol (2000) 0.84
A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. Cancer (1999) 0.84
A phase II randomized trial of megestrol acetate or dexamethasone in the treatment of hormonally refractory advanced carcinoma of the prostate. Cancer (1990) 0.83
Breast cancer and pregnancy. Semin Oncol (1989) 0.83
Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer. Clin Cancer Res (1999) 0.83
A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer (1993) 0.82
Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol (1999) 0.81
Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study. Cancer Treat Rep (1983) 0.81
Nutritional determinants of survival among patients with breast cancer. Surg Clin North Am (1999) 0.81
Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas. J Natl Cancer Inst (1989) 0.81
Phase II trial of etoposide in advanced prostate cancer. Cancer Treat Rep (1984) 0.79
Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol (1992) 0.79
In vitro induction of human skin ornithine decarboxylase by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. J Natl Cancer Inst (1985) 0.79
Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol (1997) 0.79
Palliative communications: addressing chemotherapy in patients with advanced cancer. Ann Oncol (2012) 0.79
Management of hot flashes in breast-cancer survivors. Lancet Oncol (2001) 0.79
A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer. Am J Clin Oncol (1991) 0.79
An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology (1997) 0.78
A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma. Am J Clin Oncol (1993) 0.78
Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy. Cancer (1994) 0.78
Combination chemotherapy with cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovary. Gynecol Oncol (1984) 0.78
Utility of the Arabidopsis FAE1 and yeast SLC1-1 genes for improvements in erucic acid and oil content in rapeseed. Biochem Soc Trans (2000) 0.78
Coumarin-induced hepatotoxicity. J Clin Oncol (1997) 0.78
Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer. Hosp J (1993) 0.78
Should cancer patients with incurable disease receive parenteral or enteral nutritional support? Eur J Cancer (1998) 0.77
A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma. Cancer (1988) 0.77
Inhibition of phorbol ester--induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies. J Clin Oncol (1985) 0.77
Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer (2001) 0.77
Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma. Cancer (1997) 0.76